Page 5 - Best Brain MRI doctors in Turkey: TOP 164 doctors

Experience

2019 – 2019

• University of Insubria, Varese, Italy, 

Insubria University Faculty of Medicine

2015

• MERSİN UNIVERSITY/FACULTY OF MEDICINE, DOCTOR, LECTURER

2013 – 2015

• ANKARA PRIVATE ACIBADEM HOSPITAL

2010 – 2012

• DIYARBAKIR TRAINING AND RESEARCH HOSPITAL,

2002 – 2003

• AYDIN 1ST PRIVATE TRAINING BATTALION
•  

Education

2010

• ANKARA UNIVERSITY FACULTY OF MEDICINE, BRAIN AND SURGERY SPECIALIST

1992

• GAZI UNIVERSITY, FACULTY OF MEDICINE

Dr. Halil Can is a Professor of Neurosurgery (2025; Associate Professor 2020). He completed neurosurgical training at Istanbul University–Istanbul Faculty of Medicine in 2007. His clinical focus includes endoscopic and microsurgical spine surgery for fractures, tumors, and degenerative disease; advanced pain procedures; endoscopic skull base and pituitary surgery; and neurovascular, neuro-oncologic, and peripheral nerve surgery.

He has 21 international peer-reviewed papers (SCI/SSCI). Topics include cadaveric morphometry of Kambin’s triangle and the transforaminal triangular working zone, lumbar arterial and anterior approach anatomy, and an in vitro test of a new lumbar fixation device.

His clinical studies include a single-team series of 81 posterior circulation aneurysms, with 13 flow-diversion cases. He also reported five spinal cavernous malformation cases. He conducted Phase I safety and feasibility stem-cell trials in pediatric hypoxic-ischemic encephalopathy and in chronic complete spinal cord injury.

Dr. Turgay Abay is an experienced neurologist with a strong background in adult and pediatric neurology. He has more than 10 years of experience diagnosing and treating a wide range of neurological conditions.

He completed specialist training in neurology at Gaziantep University (2008–2013). The university is a well-established Turkish institution known for high academic standards and clinical excellence. He then practiced at Siirt State Hospital (2013–2014), treating a broad range of neurological disorders in a public hospital.

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Dr. Ali Osman Mucuoglu is a neurosurgeon. He completed his neurosurgery residency at Dokuz Eylül University from 2013 to 2019 after graduating from Eskişehir Osmangazi University in 2012 (2005–2012). He worked at Dokuz Eylül University and Muş State Hospital from 2019 to 2021. He has practiced at Atlas University Hospital since 2021.

He has five publications. These include a case report in the International Journal of Surgery Case Reports that has been cited seven times. He also reported on 3D printer‑assisted transsphenoidal hypophysectomy and on emergency minimally invasive intracerebral hemorrhage (ICH) surgery. He delivered an oral presentation at the 33rd Turkish Neurosurgical Society Congress in 2019.

He is a member of the Turkish Neurosurgical Society, the European Association of Neurosurgical Societies, and the Istanbul Chamber of Medicine. His advanced training includes spinal surgery courses in 2016 and 2017, the European Training Course on Head Injury and Functional Neurosurgery in 2017, and Surgical Neuroanatomy in 2017. He also holds an animal experimentation certificate from 2016.

Education and Expertise

• 1999 – 2005 – FIRAT UNIVERSITY FACULTY OF MEDICINE
• 1995 – 1999 – IZMIR ATATURK HIGH SCHOOL

Diseases

• Alzheimer’s type dementia
• Headaches
• Dizziness
• Cerebrovascular diseases
• Vascular diseases
• Dementia Diseases
• Demyelinating Diseases
• Epilepsy
• Movement Disorders
• Migraine
• Myopathies
• MOGAD

Treatment Methods

• Botox
• Duodopa Treatment
• Intravenous Thrombolytic
• IVIG Treatment
• Migraine vaccine
• Migraine Botox

Experience

• 2005-2010 – Ege University Faculty of Medicine, Department of Neurology, Specialization Student, Izmir.
• 2010-2012 – İzmir Tire State Hospital Neurology Department
• September 2012 – May 2013 – Çanakkale 18 March University, Faculty of Medicine, Department of Neurology, Assistant Professor.
• 2013 – Medical Point Izmir Hospital Neurology Department

Professional Memberships

• Turkish Neurology Association

Assoc. Prof.  Nesrin Helvacı Yılmaz graduated from Hacettepe University in 2000 as a Medical Doctor.  She completed her specialty training in the Department of Neurology at Ankara University in 2006.

She started her compulsory service in Mardin Nusaybin State Hospital in 2007.  Nesrin Helvacı Yılmaz continued her duty in Gaziantep 27 December State Hospital in 2008.  She worked as a neurologist at Biophysis Nilüfer Medical Center and Ali Osman Sönmez Oncology Hospital in Bursa between 2010-2011, and at Istanbul Universal Aksaray Hospital between 2011-2012. From October 2012, she started to work as a Doctor Lecturer in Istanbul Medipol University Neurology Department.  Nesrin Helvacı Yılmaz received the title of associate professor in 2021.  In 2015, she worked as an Honorary Observer in Parkinson's Disease and Deep Brain Stimulation (Neuromodulation) at UCL Queen Square Institute of Neurology, National Hospital for Neurology in London.  She took part in many training programs on Deep Brain Stimulation (Neuromodulation) in Turkey and abroad between 2013-2022.

Regarding her speciality in Parkinson's disease and movement disorders, she has 5 Tubitak projects, a 2-chapter book , 30 clinical researches and 80 reports presented in domestic and abroad. Assoc. Prof. Nesrin Helvacı Yılmaz, who is still working within the staff of Medipol University, managed the Parkinson's and Movement Disorders Unit of the Department of Neurology during her working time and plans Deep Brain Stimulation therapy applications with the neurosurgical team.

Since September 2018, she has been working as a coordinator for student education in the 5th semester of Neurology. As of December 2022, she has developed treatment plans for patients at Medipol University Istanbul Parkinson's Disease and Movement Disorders Center (PARMER) and provides the most appropriate personal medical follow-up and treatment support for each patient.

PUBLICATIONS

1-Yilmaz N, Yigit A, Akbostanci MC. Clozapine induced epilepsy. Revue Neurologique 2004, Nov;160/11:1093.

2-Nesrin Helvacı Yılmaz, Nursel Aydın. Sıcak Su Epilepsili Bir Olgu. Türkiye Klinikleri Nöroloji Dergisi 2004/Cilt2/Sayı 2.

3-Nesrin Helvacı Yılmaz, Nursel Aydın. Refleks Epilepsiler. Türkiye Klinikleri Nöroloji Dergisi 2004/Cilt2/Sayı 2.

4-Mine Hayriye Sorgun, Bilge Koçer, Funda Kaplan, Nesrin Yılmaz, Nezih Yücemen, Canan Yücesan. Multipl Sklerozda Kraniyal Nöropati. Turk Norol Derg 2011;17:137-142.

5-Nesrin Helvacı Yılmaz, Gökçen Duymaz, Mehmet Akif Yaşar. Parkinson Hastalığı Olan Bir Olguda Malign Sendrom. Turk Norol Derg 2012:18;123-125.

6-Yilmaz NH, Akbostanci MC, Oto A, Aykac O. Prevalence of restless legs syndrome in Ankara, Turkey: an analysis of diagnostic criteria and awareness. Acta Neurol Belg 2012 Oct 31. [Epub ahead of print].

7-Yılmaz NH, Bingol AP. Sensitivity and specificity of Ankara University Cerebral Dominance Inventory in comparison with the Wada test. Acta Neurol Belg 2013 Jun 6 [Epub ahead of print].

8-Sema Demirci, Nesrin Helvacı Yılmaz, Efsun Şenocak, Fatih Han Bölükbaşı. Pons Kavernomu: Kranial Manyetik Rezonans Görüntüleme Bulguları. Turk Norol Derg 2012:19:72.

9-Nesrin Helvacı Yılmaz, Sinem Atik Güngör, Taflan Sahlepçi. Küçük hücreli akciğer kanseri tedavisinde cisplatin kullanımı sırasında gelişen akut iskemik inme: olgu sunumu. J Kartal TR. Baskıdaki Makaleler: KEAH-26937.

POSTERLER:

-Serebral venöz tromboz ve bruselloz Birlikteliği; Olgu Sunumu (42. Ulusal Nöroloji Kongresi-Antalya 2006)

-Waldenström makroglobulinemisine eşlik eden epileptik nöbetler ve nonkonvülsif status epileptikus (42. Ulusal Nöroloji Kongresi-Antalya 2006)

-Prevalence of Restless Legs Syndrome in Ankara, Turkey (16. Uluslararası Parkinson ve Hareket Bozuklukları Kongresi-Dublin 2012).

-Konjenital Miyastenik Sendrom (29. Ulusal Nörofizyoloji EEG-EMG Kongresi- Antalya 2013).

-Beşinci haftada duyusal iletimleri normal olan bir enjeksiyon nöropatisi olgusu (29. Ulusal Nörofizyoloji EEG-EMG Kongresi- Antalya 2013).

-Olgu sunumu: Mononöritis mültipleks ve lepra (29. Ulusal Nörofizyoloji EEG-EMG Kongresi- Antalya 2013).

-İdyopatik Parkinson Hastalığı’nda hızlanmış unutma ve uyku kalitesi (10. Ulusal Parkinson ve Hareket Bozuklukları Kongresi-Antalya 2013).

-Hiperglisemiye bağlı hemikore ve bazal gangliyon hiperintensitesi: Olgu sunumu (10. Ulusal Parkinson ve Hareket Bozuklukları Kongresi-Antalya 2013).

EDUCATION:

2014 ADNAN MENDERES UNIVERSITY FACULTY OF MEDICINE, CHILD HEALTH AND DISEASES, CHILD NEUROLOGY

2011 IZMIR EDUCATION AND RESEARCH HOSPITAL, CHILD HEALTH AND DISEASES

2011 Izmir Tepecik Education and Research Hospital, Child Health and Diseases

2004 DICLE UNIVERSITY, FACULTY OF MEDICINE

EXPERIENCE:

2018 Istanbul Medipol Hospital

2017 - 2018 Kartal Education and Research Hospital

2014 - 2016 Denizli State Hospital

2011 - 2014 Aydin Adnan Menderes University Faculty of Medicine Hospital

2006 - 2011 Izmir Tepecik Education and Research Hospital

2011Izmir Education and Research Hospital

Assoc. Prof. Dr. Burak Eren
Specialist in Brain and Nerve Surgery

Neurosurgery Areas of Interest
    •    Brain Tumors
    •    Pituitary Tumors (Endoscopic)
    •    Brain Aneurysms
    •    Skull Base Tumors
    •    Spinal and Spinal Cord Tumors
    •    Lumbar Disc Herniation
    •    Cervical Disc Herniation
    •    Spondylolisthesis
    •    Spinal Canal Stenosis
    •    Traumatic Brain and Spinal Injuries

Personal Information
    •    Date of Birth: 03/11/1979
    •    Marital Status: Married, Father of 2 children
    •    Languages: English
    •    Title: Associate Professor – 10/03/2021

Education
    •    Bachelor’s Degree: Eskişehir Osmangazi University Faculty of Medicine, 1997-2003
    •    Specialty Training: Bezmi Alem Valide Sultan Education and Research Hospital, Neurosurgery Clinic / Istanbul, 2004-2010

Professional Experience
    •    Köyceğiz SSK Dispensary / Muğla (2003-2004)
    •    Bezmi Alem Valide Sultan Education and Research Hospital / Istanbul (2004-2010)
    •    Bakırköy Dr. Sadi Konuk Education and Research Hospital / Istanbul (2010-2012)
    •    Bilecik State Hospital / Bilecik (2012-2013)
    •    Special Nisa Hospital / Istanbul (2013-2014)
    •    Bağcılar Education and Research Hospital / Istanbul (2014-2024)

Articles Published in International Peer-Reviewed Journals:
    1.    Sağlam-Çifci Ece, Güleç İlker, Şengelen Aslıhan, Karagöz-Güzey Feyza, EREN BURAK, Paşaoğlu H Esra, Önay-Uçar Evren. The H4R antagonist, JNJ-7777120 treatments ameliorate mild traumatic brain injury by reducing oxidative damage, inflammatory and apoptotic responses through blockage of the ERK1/2/NF-κB pathway in a rat model (2025). Experimental Neurology. 115133. DOI: 10.1016/j.expneurol.2024.115133.
    2.    EREN BURAK, Karagoz Guzey Feyza, Gulec Ilker, Tufan Azmi, Bas Nuri Serdar. The Importance of Spinopelvic Parameters in Recurrent Lumbar Disk Herniation. Clinical Spine Surgery, 37(3), E113-E118. (2024). DOI: 10.1097/BSD.0000000000001546.
    3.    Aycan Abdurrahman, EREN BURAK, Tas Abdurrahim. Treatment and outcomes of patients with metastatic spinal cord compression: a double-center study. European Review for Medical and Pharmacological Sciences, 27(13), 6121-6131. (2023). DOI: 10.26355/eurrev_202307_32968.
    4.    Yücel Murat, Aktaş Özgür Yusuf, Zengi Oğuzhan, Taş Abdurrahim, Tufan Azmi, EREN BURAK, Karagöz Güzey Feyza. The effect of alpha-lipoic acid on nerve tissue healing after sciatic nerve crush injury in rats. Annals of Medical Research, 30(6), 684-691. (2023). DOI: 10.5455/annalsmedres.2023.09.246.
    5.    Tufan Azmi, Aktaş Özgür, EREN BURAK, Doruk Ebru, Gulec Ilker, Taş Abdurrahim, Karagoz Guzey Feyza. Effects of Age and Co-Morbidities on Complication Rate in Surgical Treatment of Lumbar Degenerative Diseases: A Prospective Clinical Study. Eastern Journal of Medicine, 28(4). (2023). DOI: 10.5505/ejm.2023.89646.

Papers Presented at International Scientific Conferences:
    1.    EREN BURAK. Comparison of Patients Who Voluntarily Applied to the Neurosurgery Outpatient Clinic Due to Spinal Diseases and Patients Referred by Family Physicians. 19th International Eastern Mediterranean Family Medicine Congress, 1266-1267. (2020). (Abstract/Oral Presentation) (Publication No: 6514176).
    2.    EREN BURAK. Relationship Between Spinopelvic Parameters and Recurrent Lumbar Disc Herniation. World Spinal Column Society Virtual World Spine. (2020). (Abstract/Oral Presentation) (Publication No: 6514209).
    3.    Tas Abdurrahim, Karagoz Guzey Feyza, Tufan Azmi, Kuvat Nuray, Aktaş Özgür Yusuf, EREN BURAK, Yücel Murat, Kahraman Akkalp Asli. Prophylactic Effects of Silver Nanoparticles in a Rat Model of Spinal Stabilization and Infection. World Federation of Neurosurgical Societies XVI. World Congress, 33-34. (2017). (Abstract/Oral Presentation) (Publication No: 6513245).

Chapters in Scientific Books:
    1.    Klinik Nöroanatomi (Clinical Neuroanatomy), Chapter Title: (Lesions of the Hypophysis and Hypothalamus, Their Pathophysiology, and Surgical Anatomy) (2023). EREN BURAK, Tufan Azmi. Güneş Tıp Kitabevleri. Editors: Karagöz Güzey Feyza, Balcıoğlu Hüseyin Avni. 1st Edition. Page Count: 613. ISBN: 978-975-277-971-6. (Scientific Book in Turkish).
    2.    Nöroşirürjinin Temelleri (Fundamentals of Neurosurgery), Chapter Title: (Diagnosis, Classification, and Treatment of Thoracolumbar and Sacral Trauma) (2020). EREN BURAK, Karagöz Guzey Feyza. US Akademi. Editors: Naderi Sait, Karagöz Güzey Feyza, Tuğcu Bekir. 1st Edition. Page Count: 610. ISBN: 978-605-9358-. (Scientific Book in Turkish).

Articles Published in National Peer-Reviewed Journals:
    1.    EREN BURAK, Karagöz Güzey Feyza, Güleç İlker, Baş N. Serdar, Ay Ferhat, Acaroğlu Muhammed A., Çuhacıbaşı Enes B. Neurosurgery Career Preferences Compared to Other Medical Specialties among Turkish Students. Tıp Eğitimi Dünyası, 22(68), 143-153.
    2.    EREN BURAK, Gulec Ilker, Karagoz Guzey Feyza, Saglam Ece, Tufan Azmi, Karacan Murat, Bas Nuri Serdar. Evaluation of Multiple Myeloma Patients Undergoing Decompression Due to Spinal Cord Pressure. Osmangazi Journal of Medicine, 42(5), 546-552. (2020). DOI: 10.20515/otd.571004.

Technical Notes, Case Reports, Research Notes, etc.:
    1.    Case Report: EREN BURAK, Karagoz Guzey Feyza, Gulec Ilker. Craniopharyngioma and Arteriovenous Malformation Operated Using the Same Craniotomy: An Unusual Case. Romanian Neurosurgery, 34(3), 437-440. (2020). DOI: 10.33962/roneuro-2020-070.
    2.    Case Report: Tufan Azmi, EREN BURAK, Tas Abdurrahim, Berker Neslihan, Aktaş Özgür Yusuf, Gulec Ilker, Vatansever Mustafa Safi, Karacan Murat, Vahabova Günay, Karagoz Guzey Feyza. Spinal Metastasis as a Presenting Feature of Follicular Type Thyroid Carcinoma: A Case Report and Review of the Literature. Bagcilar Medical Bulletin, 4(1), 1-9. (2019). DOI: 10.4274/BMB.galenos.2019.26888.

Dr. Buse Cagla Ari, MD, is an Associate Professor of Neurology. She specializes in Parkinson’s disease and other movement disorders, headache disorders, sleep disorders, and dementia. She works at Istanbul Medipol University and the Parkinson’s Disease and Movement Disorders Center (PARMER). She previously served as an Assistant Professor at Bahcesehir University.

Her research focuses on Parkinson’s disease biomarkers, cognition, uric acid and cholesterol associations, restless legs syndrome, and complex headaches. This includes a 13-patient case series. She has published 15 international and 4 Turkish papers and 5 book chapters. Her work has 147 citations on Google Scholar (h-index 5) and 91 citations on Web of Science (h-index 5).

She is a member of the International Parkinson and Movement Disorders Society, the International Headache Society, and the Turkish Parkinson’s Disease Society. She serves as a peer reviewer for SAGE Open Medical Case Reports, BMC Neurology, and Parkinsonism & Related Disorders.

Dr. Zuhal Cakmak Peksen is a Family Medicine Specialist since 2017. She earned her MD from Çukurova University in 2010. She completed specialty training at Yüzüncü Yıl University between 2013 and 2017. She is currently studying for a bachelor’s degree in Health Management at Anadolu University (2024–present).

She has 15 years of clinical practice (2010–2025) across 8 institutions. Her experience includes research in Family Medicine (2013–2017) and work at several Family Health Centers. Since 2020, she has served at TOKİ Avrupa Family Health Center in Gaziosmanpaşa, Istanbul.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Inci Emekli is a neurologist at PARMER, Istanbul Medipol University (2025–). She specializes in Parkinson’s disease and movement disorders. She completed her neurology residency at Istanbul University (2015–2020). She then completed a neurology fellowship at Karabuk University (2020–2023) and movement disorders training at Michigan State University (2023–2024).

Her publications include an accepted article in Movement Disorders on the Head Snap Sign, a 2024 World Neurosurgery article on gender inequality in leadership, and a 2021 Parkinsonism & Related Disorders paper on hereditary Parkinson’s in Turkey. She delivered an oral presentation in 2022 on COVID‑19’s impact on carpal tunnel surgery. She also co‑authored a neurology chapter on hyperlipidemia in 2021.

Accreditation: Fellow of the Turkish Board of Neurology (2019–). Memberships: Turkish Society of Neurology (2016–) and European Academy of Neurology (2019–).

Education & Academic Background

GATA School of Military Medicine – Medical Degree

GATA Haydarpaşa Training Hospital, Neurosurgery Clinic – Specialization in Neurosurgery

Beykent University – Master’s Degree in Hospital and Health Institutions Management

Professional Experience

GATA Military Medical Faculty – Internship in General Medicine 

Samsun Field (Sahra) Medical School Command – Physician 

Naval Command, Combat Fleet, TCG Effort – Medical Officer 

Submarine Battery Factory Infirmary, Turkish Naval Forces – Physician

Shipyard Command Infirmary, Turkish Naval Forces – Physician 

GATA Haydarpaşa Training Hospital – Chief Assistant, Neurosurgery Department 

Kasımpaşa Marine Hospital – Chief of Neurosurgery Clinic 

Bahçelievler Medical Park Hospital – Neurosurgery Specialist

Altınbaş University Faculty of Medicine – Neurosurgery Lecturer

Altınbaş University Faculty of Medicine, Department of Neurosurgery – Faculty Member 

Certifications & Courses

-Basic and Advanced Cardiac Life Support (BLS & ACLS) Courses

-GATA Military Medicine Faculty – Microsurgery Training Course

-Istanbul Vatan Hospital – Hand Surgery & Microsurgery Course

-Neuroanatomy Course

-Spine Surgery Course

Professional Memberships 

-Turkish Neurosurgery Association 
-Spine Society of Europa
-Turkish Spinal and Peripheral Nerve Surgery Group

Research & Publications

Transpedicular fixation application in thoracic and lumbar stabilization, results and complications.
Yayla O, Demircan MN, Kutlay M, Çolak A, Seçer HI, Kıbıcı K, Tosyalı L, Akın ON, Alkan K. GATA Bulletin.

Effects of hyperbaric oxygen therapy on histopathological changes in acute period after crush trauma in rabbit sciatic nerve.
Akın ON, Kutlay M, Demirel D, Kıbıcı K, Elbüken E. J Atatürk Univ Med Fac.

Early diagnosis, follow-up and treatment of delayed traumatic intracerebral hematomas.
Kutlay M, Kıbıcı K, Demircan MN. Natl J Trauma.

Traumatic delayed epidural hematomas: Retrospective analysis of 7 new cases and 48 from literature.
Kutlay M, Çolak A, Kıbıcı K, Demircan MN, Akın ON. Natl J Trauma 1998.

Single vertebral body screw-rod or plate fixation for ventral thoracic spine lesions.
Kutlay M, Çolak A, Demircan MN, Akın ON, Kıbıcı K, Seçer HI, Tosyalı L. Turk Neurosurg 1999.

Peripheral nerve schwannomas.
Kutlay M, Çolak A, Akın ON, Demircan MN, Kıbıcı K, Topuz K, Başekim Ç, Demirel D. Turk J Neurosurg  1999.

Epidemiological study of traumatic spinal cord injuries.
Kutlay A, Kıbıcı K, Demircan MN. GATA Bulletin  1999.

Hyperbaric oxygen treatment on fetal spinal cord grafts: Preliminary study.
Kutlay M, Çolak A, Demircan MN, Akın ON, Kıbıcı K, Dündar K, Yıldırım Ş. Turk Neurosurg, 1999.

Corpus callosum lipomas with frontal subcutaneous lipomas.
Çolak A, Kutlay M, Başekim Ç, Kıbıcı K, Demircan MN. Gülhane Med J,  2000.

Morphometric study with image analysis system in meningiomas.
Kıbıcı K, Kutlay M, Çolak A, Demircan MN, Akın ON, Baloğlu H. Turk J Neurosurg, 2003.

Morton Neuroma with Tarsal Tunnel Syndrome: Case report.
Kıbıcı K, Demircan MN, Kıral A, Çolak A, Kutlay M, Akın ON. Turk J Neurosurg, 2006.

Carpal tunnel surgery with mini open technique: Functional results.
Kıbıcı K. Turk J Neurosurg, 2010.

Surgical treatment of common peroneal nerve entrapment: Clinical study.
Kıbıcı K. Turk J Neurosurg,  2010.

Cauda equina syndrome after sacrum transverse fracture: Case report.
Köksal V, Kıbıcı K. Turk J Neurosurg,  2010.

Schwannoma from sensory sural nerve: Case report.
Köksal V, Kıbıcı K. Erciyes Med J,  2013.

Clinical analysis of wrist drop due to radial tunnel syndrome.
Köksal V, Kıbıcı K, Kırbaş S. Indian J Med Res Pharm Sci,  2016.

Spinal subdural hematoma after minimally invasive lumbar discectomy.
Kıbıcı K, Atca AÖ, Erok B, Gültekin MZ. J Clin Rev Case Rep,  2019.

Rare variant of vertebral artery originating from external carotid artery.
Kıbıcı K, Atca AÖ, Erok B. J Clin Rev Case Rep,  2019.

Minimally invasive surgical treatment of piriformis syndrome.
Kıbıcı K, Atca AÖ, Erok B. J Clin Rev Case Rep,  2019.

Large suprasellar psammomatous meningioma: A rare variant.
Erok B, Kıbıcı K, Kaya RA. Pak J Radiol,  2020.

Large pericallosal lipoma after traumatic head injury: Case report.
Erok B, Kıbıcı K, Atca AÖ. Pak J Radiol,  2020.

Fungating orbital mass as presentation of retinoblastoma.
Kıbıcı K, Erok B, Akın O. J Acad Res Med, 2020.

Ligamentum flavum hematoma with L5-S1 pars defect: Case report.
Kıbıcı K, Erok B, Akın O. Indian J Neurosurg,  2020.

Radiation-induced brachial plexopathy in breast cancer: Surgical role.
Kıbıcı K, Erok B, Atca AÖ. Indian J Neurosurg, , 2020.

Drop foot due to peroneal intraneural ganglion: Case report.
Kıbıcı K, Erok B, Akın O. Indian J Neurosurg,  2020.

Surgical decompression of lateral femoral cutaneous nerve in meralgia paresthetica.
Kıbıcı K, Erok B, Atca AÖ. Indian J Neurosurg,  2020.

Pulmonary cavitation in COVID-19: Primary or secondary?
Erok B, Kıbıcı K, Atca AÖ. Afr J Respir Med,  2020.

Posterior dynamic stabilization for bilateral L5 pars defect.
Kıbıcı K, Erok B. Turk Neurosurg, , 2020.

Incidental MRI appearance of COVID-19 pneumonia.
Atca AÖ, Erok B, Kıbıcı K. Afr J Respir Med,  2020.

Orbital rhabdomyosarcoma in Li-Fraumeni syndrome.
Erok B, Kıbıcı K. Eur J Clin Exp Med,  2021.

Chest CT features of progressive COVID-19 pneumonia.
Erok B, Atca AÖ, Kıbıcı K. Acta Med Mediterr, 2021.

Dr. Alper Karaoglan is a Professor of Neurosurgery at Memorial Bodrum Hospital. He has many years of experience in neurosurgery. He worked at Maltepe University Faculty of Medicine and Taksim Training and Research Hospital in Istanbul. Since 2008, he has held the positions of Professor, Associate Professor, and Assistant Professor in neurosurgery.

Dr. Karaoglan is a member of the Turkish Medical Association and the Turkish Neurosurgical Society. He has received several awards. These include the Best Paper Award at the Turkish Neurosurgical Society Scientific Congress in 2005 for his research on resveratrol’s protective effects after subarachnoid hemorrhage, and the Young Neurosurgeon Encouragement Award in 2008.

Dr. Ela Simay Zengin is a neurologist. She completed her medical training at Dokuz Eylül University, Başkent University, and Acıbadem University. She has worked at Bitlis Tatvan, Sirnak, and Cizre State Hospitals.

Dr. Zengin treats Alzheimer’s disease, epilepsy, migraines, multiple sclerosis, Parkinson’s disease, and stroke. She uses advanced treatments, including apomorphine pump therapy, botulinum toxin injections, and migraine vaccines.

She is a member of the Turkish Neurology Association, American Academy of Neurology, European Academy of Neurology, and International Parkinson and Movement Disorder Society.

Dr. Ulvi Samadzade is a neurologist with training from Azerbaijan State Medical University, Gazi University, and Dokuz Eylul University Hospital. He diagnoses and treats neurological disorders such as Alzheimer’s disease, epilepsy, movement disorders, stroke, migraine, and multiple sclerosis.

Dr. Samadzade uses advanced treatments, including botulinum toxin injections, intravenous immunoglobulin (IVIG) therapy, migraine vaccines, and plasmapheresis. He practices at İzmir University of Economics Medical Point Hospital.

He is a member of several professional organizations. These include the Multiple Sclerosis Research Association, Turkish Neurological Society, European Academy of Neurology, and the International Parkinson and Movement Disorder Society (MDS).

Dr. Evren Sandal is a specialist in Brain and Neurosurgery. He completed his medical degree at Ege University Faculty of Medicine. He finished his neurosurgery training in 2015. Dr. Sandal focuses on skull base, craniocervical junction, and neurovascular surgery. He has extensive experience in these fields.

Dr. Sandal has worked at the Health Sciences University Tepecik Training and Research Hospital. He also contributed to laboratory and clinical studies in skull base and cerebral bypass surgery at the University of Wisconsin, USA. He has collaborated with experts such as Prof. Dr. M. Sedat Çağlı and Prof. Başkaya. These experiences have strengthened his skills in complex neurosurgical procedures.